Nachrichten zur United Therapeutics Corp. Aktie

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.…

IRW-PRESS: Thiogenesis Therapeutics Corp.: Thiogenesis erhält positive Rückmeldung zur Einreichung eines IMPD für die klinische Phase-2a-Studie zu MASH bei Kindern…

IRW-PRESS: Thiogenesis Therapeutics Corp.: Thiogenesis gibt zweites Prüfzentrum bekannt, beginnt mit der Rekrutierung für die klinische Phase-2-Studie MELAS und veröffentlicht…

…

IRW-PRESS: Thiogenesis Therapeutics Corp.: Thiogenesis gibt FDA-Genehmigung für seinen Antrag auf Zulassung eines neuen Prüfpräparats (IND) für eine klinische Phase-2-Studie…

United Therapeutics (UTHR) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

IRW-PRESS: Thiogenesis Therapeutics Corp.: Thiogenesis leitet klinische Phase-2-Studie zur mitochondrialen Enzephalomyopathie mit Laktatazidose und schlaganfallähnlichen Episoden (MELAS) einSan Diego, Kalifornien,…

MORRISVILLE, N.C., May 12, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies…

MORRISVILLE, N.C., May 02, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies…

United Therapeutics reports better-than-expected first-quarter 2025 results, beating both earnings and revenue estimates, driven mainly by strong Tyvaso sales.…

United Therapeutics (UTHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…

United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…

…

United Therapeutics (UTHR) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

United Therapeutics (UTHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings…

United Therapeutics president Michael Benkowitz sells $3.57 million in stock…

We think all investors should try to buy and hold high quality multi-year winners. And weve seen some truly amazing...…

…

…

UTHR reports better-than-expected results in third-quarter 2024 on the back of strong demand for its treprostinil medications, especially Tyvaso.…

Stocks to watch include Uber Technologies and United Therapeutics.…

Texas Roadhouse, Uber and United Therapeutics are among the best stocks to watch.…

United Therapeutics (UTHR) ist auf die Entwicklung und Kommerzialisierung von Produkten zur Behandlung der pulmonal-arterielle Hypertonie (PAH) spezialisiert. Vor allem…

Am Dienstag sieht es zunächst nach einem ruhigen Handelsauftakt an der New Yorker Wall Street aus. Zum Wochenauftakt hatte der…

Der Rekordlauf an der Wall Street setzte sich auch zu Wochenbeginn fort. Erneut erklommen Dow Jones und S&P 500 neue…

MORRISVILLE, N.C., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (Liquidia), a biopharmaceutical company developing innovative…

United Therapeutics (UTHR) is well positioned to outperform the market, as it exhibits above-average growth in financials.…

…

Earnings call: United Therapeutics reports strong Q1 with record revenue…

United Therapeutics (UTHR) first-quarter 2024 earnings and sales beat estimates. Tyvaso sales continue to drive the companys top line.…

…

United Therapeutics CEO sells over $7 million in company stock…

United Therapeutics initiates $1 billion stock buyback…

…

AUSTIN. Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Benuvia Operations, LLC (“Benuvia”), a leader in pharmaceutical innovation, and…